Literature DB >> 27474233

Triggering Intracellular Receptors for Vaccine Adjuvantation.

Alice Gutjahr1, Gérard Tiraby2, Eric Perouzel2, Bernard Verrier3, Stéphane Paul4.   

Abstract

Immune adjuvants are components that stimulate, potentiate, or modulate the immune response to an antigen. They are key elements of vaccines in both the prophylactic and therapeutic domains. In the past decade substantial progress in our understanding of innate immunity has paved the way for the design of next-generation adjuvants that stimulate a wide range of receptors. Within the framework of vaccine adjuvant design, this review outlines the interest of targeting endosomal and intracellular receptors to enhance and guide the immune response. We present and compare the molecules as well as potential combinations which are currently in the spotlight. We emphasize how targeting the appropriate receptor can direct immunity towards the appropriate response, such as a cytotoxic or mucosal response.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 27474233     DOI: 10.1016/j.it.2016.07.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  16 in total

1.  The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.

Authors:  Alice Gutjahr; Laura Papagno; Francesco Nicoli; Tomohiro Kanuma; Nozomi Kuse; Mariela Pires Cabral-Piccin; Nicolas Rochereau; Emma Gostick; Thierry Lioux; Eric Perouzel; David A Price; Masafumi Takiguchi; Bernard Verrier; Takuya Yamamoto; Stéphane Paul; Victor Appay
Journal:  JCI Insight       Date:  2019-04-04

Review 2.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

3.  An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.

Authors:  Hiroki Tsukamoto; Kanae Kubota; Ayumi Shichiku; Masamitsu Maekawa; Nariyasu Mano; Hideo Yagita; Shoichiro Ohta; Yoshihisa Tomioka
Journal:  Immunology       Date:  2019-10       Impact factor: 7.397

4.  Environmentally Triggerable Retinoic Acid-Inducible Gene I Agonists Using Synthetic Polymer Overhangs.

Authors:  Christian R Palmer; Max E Jacobson; Olga Fedorova; Anna M Pyle; John T Wilson
Journal:  Bioconjug Chem       Date:  2018-01-19       Impact factor: 4.774

Review 5.  Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.

Authors:  John J Suschak; James A Williams; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 6.  Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.

Authors:  Andri Vasou; Nazife Sultanoglu; Stephen Goodbourn; Richard E Randall; Leondios G Kostrikis
Journal:  Viruses       Date:  2017-07-13       Impact factor: 5.048

7.  Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization.

Authors:  Francesco Borriello; Carlo Pietrasanta; Jacqueline C Y Lai; Lois M Walsh; Pankaj Sharma; David N O'Driscoll; Juan Ramirez; Spencer Brightman; Lorenza Pugni; Fabio Mosca; David J Burkhart; David J Dowling; Ofer Levy
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

8.  Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens.

Authors:  Isidoro Martínez; Juan C Oliveros; Isabel Cuesta; Jorge de la Barrera; Vicente Ausina; Cristina Casals; Alba de Lorenzo; Ernesto García; Belén García-Fojeda; Junkal Garmendia; Mar González-Nicolau; Alicia Lacoma; Margarita Menéndez; David Moranta; Amelia Nieto; Juan Ortín; Alicia Pérez-González; Cristina Prat; Elisa Ramos-Sevillano; Verónica Regueiro; Ariel Rodriguez-Frandsen; Dolores Solís; José Yuste; José A Bengoechea; José A Melero
Journal:  Front Microbiol       Date:  2017-03-01       Impact factor: 5.640

Review 9.  The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants.

Authors:  Sae-Hae Kim; Yong-Suk Jang
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

Review 10.  Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.

Authors:  Alice Gutjahr; Capucine Phelip; Anne-Line Coolen; Claire Monge; Anne-Sophie Boisgard; Stéphane Paul; Bernard Verrier
Journal:  Vaccines (Basel)       Date:  2016-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.